Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMPOWER: Phexxi Contraceptive Efficacy and Safety
NCT03243305Phase 3Completed
- Sponsor
- Evofem Biosciences, Inc.
- Start
- Jul 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of potassium bitartrate in pregnancy, sponsored by Evofem Biosciences, Inc. Primary endpoint: Number of Subjects With Pregnancy Outcomes to Measure Contraceptive Efficacy. Started Jul 2017; status: completed.
02
Drugs
potassium bitartrate
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT03243305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03243305.